Repeat dosing of oncolytic adenovirus ONCOS-102 is associated with enhanced and persistent immune responses and improved systemic activity in anti-PD-1 resistant/refractory (R/R) melanoma Meeting Abstract

  

Authors:	Shoushtari, A.; Ottesen, L.; Levitsky, V.; Hansen, T. B.; Hornyak, T.; Olszanski, A.; Nyakas, M.; Wolchok, J.
Abstract Title:	Repeat dosing of oncolytic adenovirus ONCOS-102 is associated with enhanced and persistent immune responses and improved systemic activity in anti-PD-1 resistant/refractory (R/R) melanoma
Meeting Title:	37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022)
Journal Title:	Journal for ImmunoTherapy of Cancer
Volume:	10
Issue:	Suppl. 2
Meeting Dates:	2022 Nov 8-12
Meeting Location:	Boston, MA
ISSN:	2051-1426
Publisher:	Biomed Central Ltd
Date Published:	2022-11-01
Start Page:	A647
Language:	English
ACCESSION:	WOS:000919423400576
DOI:	10.1136/jitc-2022-SITC2022.0615
PROVIDER:	wos
Notes:	Meeting Abstract: 615 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/206241